Tolera Therapeutics - Bringing Targeted and Safer Therapies to Market
Product Pipeline

Novel Cell Therapy

For immune modulation.

Dr. Siemionow’s research into the induction of tolerance has led to promising work in developing immune modulation through cell therapy. These discoveries have potential applications in organ transplantation, as well as in the treatment of autoimmune disease and cancer. Tolera plans on exploring a number of approaches to commercializing Dr. Siemionow’s work.